Haval Shirwan
Chair in Autoimmune Disease Department of Microbiology and Immunology Director of the Molecular Immunomodulation Program at the Institute for Cellular Therapeutics University of Louisville USA
Biography
Dr Shirwan is Dr Michael and Joan Hamilton Endowed Chair in Autoimmune Disease Professor of Microbiology and Immunology and the Director of the Molecular Immunomodulation Program at the Institute for Cellular Therapeutics. He conducted his graduate studies at the University of California in Santa Barbara CA and postdoctoral studies at California Institute of Technology in Pasadena CA. He joined the University of Louisville in 1998 after holding academic appointments at various institutions in the United States. Dr Shirwans research focuses on the modulation of immune system for the treatment of immunebased diseases with particular focus on type 1 diabetes transplantation and development of vaccines against infections and cancer. Dr Shirwan is widely published lectured at various national/international conferences served on various federal and nonprofit funding agencies and is on the Editorial Board of nine scientific journals He is a member of several national and international societies and recipient of various awards.
Abstract
Abstract : Exploiting synergy between TNFR and TLR4 signaling for the development of adjuvant systems
